Total Payments
$123,290
2024 Payments
$58,650
Companies
8
Transactions
74
Medicare Patients
7,076
Medicare Billing
$1.6M
Payment Breakdown by Category
Consulting$122,550 (99.4%)
Other$625.06 (0.5%)
Food & Beverage$114.52 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $122,550 | 66 | 99.4% |
| Long term medical supply or device loan | $525.00 | 1 | 0.4% |
| Food and Beverage | $114.52 | 6 | 0.1% |
| Debt forgiveness | $100.06 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Plasma Inc. | $122,550 | 66 | $0 (2024) |
| Baxter Healthcare | $625.06 | 2 | $0 (2022) |
| PFIZER INC. | $33.06 | 1 | $0 (2022) |
| Exeltis, USA Inc. | $19.48 | 1 | $0 (2022) |
| Flexion Therapeutics, Inc. | $17.72 | 1 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $15.93 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $15.64 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $12.69 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58,650 | 38 | CSL Plasma Inc. ($58,650) |
| 2023 | $63,900 | 28 | CSL Plasma Inc. ($63,900) |
| 2022 | $709.17 | 6 | Baxter Healthcare ($625.06) |
| 2020 | $17.72 | 1 | Flexion Therapeutics, Inc. ($17.72) |
| 2018 | $12.69 | 1 | AstraZeneca Pharmaceuticals LP ($12.69) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| 12/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| 12/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $720.00 | General |
| 11/27/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| 11/27/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| 11/27/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $720.00 | General |
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| 11/13/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| 11/06/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| 10/30/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| 10/30/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| 10/30/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $720.00 | General |
| 10/09/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| 09/25/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| 09/25/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| 09/25/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 09/25/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $720.00 | General |
| 09/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| 09/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| 09/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $720.00 | General |
| 08/28/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| 08/14/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| 07/10/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| 06/26/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| 06/12/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,960 | 102,465 | $1.3M | $454,379 |
| 2022 | 13 | 2,106 | 56,582 | $1.2M | $462,026 |
| 2021 | 13 | 1,708 | 63,965 | $1.1M | $463,657 |
| 2020 | 16 | 1,302 | 32,413 | $532,578 | $229,457 |
Total Patients
7,076
Total Services
255,425
Medicare Billing
$1.6M
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2023 | 223 | 28,175 | $551,982 | $153,296 | 27.8% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 278 | 1,174 | $261,327 | $108,234 | 41.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 280 | 1,180 | $227,096 | $70,367 | 31.0% |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | Office | 2023 | 241 | 45,073 | $84,126 | $50,893 | 60.5% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 177 | 1,165 | $66,149 | $20,050 | 30.3% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2023 | 40 | 1,440 | $52,454 | $18,875 | 36.0% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 166 | 573 | $40,031 | $14,591 | 36.4% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 69 | 22,500 | $17,752 | $6,712 | 37.8% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2023 | 172 | 615 | $15,990 | $4,266 | 26.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 62 | 69 | $7,150 | $2,494 | 34.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 53 | 53 | $7,851 | $2,413 | 30.7% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 42 | $5,170 | $2,027 | 39.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 176 | 406 | $5,983 | $161.61 | 2.7% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2022 | 177 | 14,025 | $392,150 | $165,275 | 42.1% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2022 | 314 | 1,050 | $222,999 | $101,861 | 45.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 314 | 1,050 | $129,654 | $54,765 | 42.2% |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 2022 | 98 | 5,675 | $150,389 | $54,050 | 35.9% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2022 | 222 | 1,160 | $70,946 | $20,962 | 29.5% |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | Office | 2022 | 309 | 30,864 | $54,321 | $19,631 | 36.1% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2022 | 33 | 1,184 | $44,708 | $15,551 | 34.8% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2022 | 194 | 577 | $40,552 | $15,304 | 37.7% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2022 | 220 | 662 | $18,112 | $4,792 | 26.5% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2022 | 17 | 70 | $11,599 | $4,167 | 35.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 55 | 55 | $8,234 | $3,122 | 37.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 58 | 65 | $5,811 | $2,475 | 42.6% |
About Dr. Candice Winful, M.D
Dr. Candice Winful, M.D is a Family Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386842771.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Candice Winful, M.D has received a total of $123,290 in payments from pharmaceutical and medical device companies, with $58,650 received in 2024. These payments were reported across 74 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($122,550).
As a Medicare-enrolled provider, Winful has provided services to 7,076 Medicare beneficiaries, totaling 255,425 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Sports Medicine, Family Medicine
- Location Houston, TX
- Active Since 07/06/2007
- Last Updated 09/23/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386842771
Products in Payments
- Hillrom - CardioPerfect PRO ECG Recorder (Device) $525.00
- PREVNAR 13 (Biological) $33.06
- SLYND (Drug) $19.48
- Zilretta (Drug) $17.72
- Belbuca (Drug) $15.93
- LEQVIO (Drug) $15.64
- SYMBICORT (Drug) $12.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Houston
Shannon Schrader, Md, MD
Family Medicine — Payments: $383,042
Family Medicine $383,042
Dr. Eric Nolen, Md, Mba, MD, MBA
Family Medicine — Payments: $158,026
Family Medicine $158,026
Dr. Joe Pouzar, M.d, M.D
Family Medicine — Payments: $104,957
Family Medicine $104,957
Victor Escobar, M.d, M.D
Family Medicine — Payments: $79,840
Family Medicine $79,840
Dr. Oscar De Valle, M.d, M.D
Family Medicine — Payments: $78,226
Family Medicine $78,226
Ms. Guljeet Sohal, M.d, M.D
Family Medicine — Payments: $72,886
Family Medicine $72,886